Top 3 Opportunities to Transform the Cannabis Industry in 2025:

• Rescheduling and State Rights: The ongoing hearing to reschedule cannabis from Schedule I to Schedule III might be completed by late 2025. Also, the Trump administration has signaled their support for state rights to legalize the drug.
• Uplisting Opportunities: Uplisting American cannabis companies from over-the-counter markets to major stock exchanges like the NYSE or NASDAQ is a crucial step for the industry’s growth and would be a boon for the cannabis stocks currently suffering lows.
• Safe Banking Act and Institutional Investment: These measures are critical to unlocking institutional investment, as the industry is currently supported by 95% retail investors.

The US cannabis industry is on the brink of significant transformation, with 2025 poised to bring pivotal changes. Three key developments could redefine the industry this year if they successfully go through: rescheduling cannabis, state rights for legalization, and uplisting on major stock exchanges.

The Department of Justice is expected to finalize the rescheduling of cannabis from Schedule I to Schedule III by late 2025. This shift sets the stage for federal recognition of cannabis in healthcare and business, a long-awaited move for the industry.

At the state level, the Trump administration has voiced support for states’ rights to regulate cannabis without federal interference. While this aligns with the broader philosophy of localized governance, it will likely result in a patchwork of regulations. However, it provides a clear path for states to move forward with legalization and regulatory frameworks.

Uplisting American cannabis companies to major exchanges like the NYSE and NASDAQ is perhaps the most anticipated change. Uplisting would increase liquidity, attract institutional investors, and provide stability—critical for an industry plagued by market volatility.

For this to happen, the Safe Banking Act must include provisions offering safe harbor to financial institutions and stock exchanges handling cannabis businesses. Additionally, the Act must address compliance with FinCEN regulations, which require financial institutions to monitor and report cannabis-related activities. These measures would allow institutional investors to confidently enter the space, shifting the industry from being 95% retail-driven to a broader investor base.

While challenges remain, including regulatory hurdles and rising competition, the potential for growth is undeniable. If rescheduling, state rights, and uplisting align with banking reform, the cannabis industry will be positioned for unprecedented expansion.